Urinary δ-Aminolevulinic Acid as a Biological Indicator throughout Penicillamine Therapy in Lead Intoxication

References

• Chisolm J. J. The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood J Pediatr 1968 73 1 38
   PubMed Web of Science ®Google Scholar
• Goldberg A. Smith J. A. Lochhead A. N. Treatment of lead poisoning with oral penicillamine Br. Med J 1 1963 1270 75
   Google Scholar
• Harris C. E. C. A comparison of intravenous calcium disodium versenate and oral penicillamine in promoting elimination of lead Can Med Assoc J 1958 79 664 66
   PubMedGoogle Scholar
• Ohlsson W. T. L. Penicillamine as a lead chelating substance in man Br Med J 1962 1 1454 56
   PubMedGoogle Scholar
• Cramer K. D-penicillamine and N-acetyl D-penicillamine in lead poisoning Postgrad Med J 50: (Aug Suppl) 1974 14 16
   Google Scholar
• Beattie A. D. Diagnostic and therapeutic uses of D penicillamine in lead poisoning Postgrad Med J (Aug Suppl) 1974 50 17 20
   PubMed Web of Science ®Google Scholar
• Selander S. Treatment of lead poisoning A comparison between the effects of sodium calcium edetate and penicillamine administered orally and intravenously. Br JInd Med 1967 24 272 81
   Google Scholar
• Selander S. Cramer K. Hallberg L. Studies in lead poisoning. Oral therapy with penicillamine: Relationship between lead in blood and another laboratory tests Br J Ind Med 1966 23 282 91
   PubMedGoogle Scholar
• Sachs H. K. Blanksma L. A. Murray E. F. O’Connell M. J. Ambulatory treatment of lead poisoning: Report of 1, 155 cases Pediatrics 1970 46 389 96
   PubMed Web of Science ®Google Scholar
• Cramer K. Selander S. Penicillamine in lead poisoning Postgrad Med J 44: (Oct Suppl) 1968 45 48
   Google Scholar
• Davis J. R. Abrahams R. H. Fishbein W. I. Fabrega E. Urinary delta-aminolevulinic acid (ALA) levels in lead poisoning Arch Environ Health 1968 17 164 71
   PubMed Web of Science ®Google Scholar
• Torkington P. Bhalla K. K. Lead poisoning with low blood lead levels Postgrad Med J 1974 50 240 42
   PubMed Web of Science ®Google Scholar
• Chisolm J. J. Barrett M. B. Harrison H. V. Indicators of internal dose of lead in relation to derangement in heme synthesis Johns Hopkins Med J 1975 137 6 12
   PubMedGoogle Scholar
• Chisolm J. J. Barrett M. B. Mellits E. D. Dose effect and dose response relationships for lead in children Pediatrics 1975 87 1152 60
   Web of Science ®Google Scholar
• Zurlo N. Meschia G. Microdeterminazione tritrimetrica del piombo con ditizene nelTaria e nei materiall biologic Med Lab (Stuttg) 1954 45 668 74
   Google Scholar
• Davis S. R. Andelman S. L. Urinary delta aminolevulinic acid levels in lead poisoning 1 A modified method for the rapid determination of urinary delta-aminolevulinic acid using disposable ion-exchange chromatography. Arch Environ Health 1967 15 53 59
   PubMed Web of Science ®Google Scholar
• Bray’s Clinical Laboratory Methods , 7th edited by Bauer J. D. Ackerman P. G. Toro G. 1968 St. Louis: C. V. Mosby 41 42
   Google Scholar
• Tomokuni K. Delta-aminolevulinic acid dehydratase test for lead exposure Arch Environ Health 1974 29 274 81
   PubMed Web of Science ®Google Scholar
• Keppler J. F. Maxfield M. E. Moss W. D. Tietjen G. Linch A. L. Interlaboratory evaluations of the reliability of blood lead analysis Am Ind Hyg Assoc J 1970 31 412 29
   PubMed Web of Science ®Google Scholar
• Westerman M. P. Pfitzer E. Ellis L. D. Jeusen W. N. Concentrations of lead in bone in plumbism NEngl J Med 1965 213 1246 50
   Web of Science ®Google Scholar
• Beritic T. Lead concentration found in human blood in association with lead colic Arch Environ Health 1971 23 289 91
   PubMed Web of Science ®Google Scholar
• Gibson S. L. Mackenzie J. C. Goldberg A. The diagnosis of industrial lead poisoning Br J Ind Med 1968 25 40 51
   PubMedGoogle Scholar
• Molina B. G. Zuñiga Ch. M. A. Sanchez A. F. J. Determinacio’n del ácido delta-aminolevulinico en población expuesta a plomo Arch Invest Med (Mex) 1976 7 115 22
   PubMedGoogle Scholar
• Hammond P. B. The relationship between inhibition of delta aminolevulinic acid dehydratase by lead and lead mobilization by ethlenediaminetetraacetate (EDTA) Toxicol ApplPharmacol 1973 26 466 75
   Web of Science ®Google Scholar
• Hammond P. B. The effects of D-penicillamine on the tissue distribution and excretion of lead Toxicol Appl Pharmacol 1973 26 241 46
   PubMed Web of Science ®Google Scholar
• Vitale L. F. Fine B. P. Barth A. Filkin K. Urinary excretion of delta-aminolevulinic acid after discontinuance of therapy for lead poisoning A test for adequacy of therapy. JPediatr 1972 81 977 79
   PubMed Web of Science ®Google Scholar
• Vitale L. F. Bailon A. R. Folland D. Brennen J. F. McCormik B. Oral penicillamine therapy for chronic lead poisoning in children JPediatr 1973 83 1041 45
   PubMed Web of Science ®Google Scholar
• Hardy H. L. Chamberlin R. I. Maloof C. C. Boylen G. W. Howell M. C. Lead as an environmental poison Clin Pharmacol Ther 1971 12 982 1002
   PubMed Web of Science ®Google Scholar
• Teisinger J. Biochemical responses to provocative chelation by edetate disodium calcium Arch Environ Health 1971 23 280 83
   PubMed Web of Science ®Google Scholar